Sage Journals: Discover world-class research

Open access

Review article

First published 2023

The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia

Robert Briski, Guillermo Garcia-Manero, Hagop Kantarjian [...]

Therapeutic Advances in Hematology

Open access

Review article

First published 2021

Venetoclax-containing regimens in acute myeloid leukemia

Ibrahim Aldoss, Vinod Pullarkat, Anthony S. Stein

Therapeutic Advances in Hematology

Open access

Review article

First published 2022

Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia

Curtis A. Lachowiez, Himachandana Atluri, Courtney D. DiNardo

Therapeutic Advances in Hematology

Open access

Research article

First published 2022

Combined Effects of Tanshinone IIA and an Autophagy Inhibitor on the Apoptosis of Leukemia Cells via p53,Apoptosis-Related Proteins and Oxidative Stress Pathways

Ying-Chyi Song, Cheng-Chieh Kuo, Chuan-Teng Liu [...]

Integrative Cancer Therapies

Open access

Review article

First published 2025

Recent advances of CAR-T cells in acute myeloid leukemia

Huan Deng, Qi Wang, Xiaodong Tong [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2021

A novel treatment regimen of granulocyte colony-stimulating factor combined with ultra-low-dose decitabine and low-dose cytarabine in older patients with acute myeloid leukemia and myelodysplastic syndromes

Huan Zhu, Bin Yang, Jia Liu [...]

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2012-11

The Role of Decitabine for the Treatment of Acute Myeloid Leukemia

Alex Ganetsky

Annals of Pharmacotherapy

Free access

Review article

First published 2014-12

Clinical potential of elacytarabine in patients with acute myeloid leukemia

Lindsay A. M. Rein, David A. Rizzieri

Therapeutic Advances in Hematology

Open access

Review article

First published 2020

Emerging treatment options for patients with high-risk myelodysplastic syndrome

Jan Philipp Bewersdorf, Hetty Carraway, Thomas Prebet

Therapeutic Advances in Hematology

Open access

Review article

First published 2024

Clinical activity,pharmacokinetics,and pharmacodynamics of oral hypomethylating agents for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: A multidisciplinary review

Ryan Haumschild, Julie Kennerly-Shah, Lisa Barbarotta [...]

Journal of Oncology Pharmacy Practice

Search results